| 16645 |
|
Powell S.M. (ed.) |
Colorectal Cancer: Methods and Protocols |
2000 | •• |
| 16646 |
|
Morgan B.P. |
Complement Methods and Protocols |
2000 | •• |
| 16649 |
|
Gavin R.H. |
Cytoskeleton Methods and Protocols |
2000 | •• |
| 16652 |
|
Vaughan P. |
DNA Repair Protocols. Prokaryotic Systems |
2000 | •• |
| 16655 |
|
Osheroff N., Bjornsti M.A. |
DNA Topoisomerase Protocols. Volume II |
2000 | •• |
| 16660 |
|
Lo C.W., Tuan R.S. |
Developmental Biology Protocols. Volume II |
2000 | •• |
| 16661 |
|
Lo C.W., Tuan R.S. |
Developmental Biology Protocols. Volume III |
2000 | •• |
| 16664 |
|
George A.J.T., Urch C.E. |
Diagnostic and Therapeutic Antibodies |
2000 | •• |
| 16668 |
|
Francis G.E., Delgado C. |
Drug Targeting, Strategies, Principles, and Applications |
2000 | •• |
| 16670 |
|
Vilcek J. |
Cytokines Engaged in Antiviral Action, Macrophage Activation, Angiogenesis, and Regulation of Cell Growth and Differentiation |
2000 | •• |
| 16674 |
|
Jaroszeski M.J., Heller R., Gilbert R. |
Electrochemotherapy, Electrogenetherapy, and Transdermal Drug Delivery |
2000 | •• |
| 16681 |
|
Ashkenazi A. |
DR4, DR5, DcR1, DcR2 |
2000 | •• |
| 16683 |
|
Ashkenazi A. |
DcR3 |
2000 | •• |
| 16685 |
|
Ganz T. |
Defensins |
2000 | •• |
| 16692 |
|
Ahuja S.K. |
ECRF3 |
2000 | •• |
| 16693 |
|
Nomiyama H., Yoshie O. |
ELC |
2000 | •• |
| 16697 |
|
Galin F., Blalock J. |
Endorphins |
2000 | •• |
| 16698 |
|
Papathanassiu A., Grella D., Sim B. |
Endostatin |
2000 | •• |
| 16701 |
|
White J. |
Eotaxin 2 |
2000 | •• |
| 16702 |
|
Williams T.J., Sabore I. |
Eotaxin |
2000 | •• |
| 16704 |
|
Spivak J. |
Erythropoietin |
2000 | •• |
| 16709 |
|
Nagata S. |
Fas Ligand |
2000 | •• |
| 16710 |
|
Nagata S. |
Fas |
2000 | •• |
| 16714 |
|
Radbruch A. (ed.) |
Flow Cytometry and Cell Sorting |
2000 | •• |
| 16717 |
|
Greaves D., Schall T.J. |
Fractalkine |
2000 | •• |
| 16718 |
|
Bock G. (ed.), Cohen D. (ed.), Goode J. (ed.) |
From Genome to Therapy: Integrating New Technologies With Drug Development |
2000 | •• |
| 16721 |
|
Nagata S. |
G-CSF Receptor |
2000 | •• |
| 16722 |
|
Nagata S. |
G-CSF |
2000 | •• |
| 16723 |
|
Wuyts A., Proost P, Van Damme J. |
GCP-2 |
2000 | •• |
| 16724 |
|
Vinay D., Kwon B. |
GIT Receptor |
2000 | •• |
| 16725 |
|
Nicola N. |
GM-CSF Receptor |
2000 | •• |
| 16726 |
|
Nicola N. |
GM-CSF |
2000 | •• |
| 16736 |
|
Salcedo T. |
ÍÑÑ-1 |
2000 | •• |
| 16743 |
|
Chappel S., Murphy W. |
Growth Hormone |
2000 | •• |
| 16749 |
|
Ware C.F. |
HVEM |
2000 | •• |
| 16753 |
|
Faguet G.B. (ed.) |
Hematologic Malignancies, Methods and Techniques |
2000 | •• |
| 16755 |
|
Nicola N. |
Hematopoietic Growth Factors |
2000 | •• |
| 16756 |
|
Miyajima A. |
Hematopoietic Receptor Family |
2000 | •• |
| 16761 |
|
Machida C.A. (ed.) |
Adrenergic Receptor Protocols |
2000 | •• |
| 16765 |
|
Kresina T.F. (ed.) |
An Introduction to Molecular Medicine and Gene Therapy |
2000 | •• |
| 16766 |
|
Wang D. (ed.) |
Angiotensin Protocols |
2000 | •• |
| 16778 |
|
Furr A.K. |
CRC Handbook of Laboratory Safety |
2000 | •• |
| 16783 |
|
Cheng J., Mitchelson K.R. |
Capillary Electrophoresis of Nucleic Acids. (Volume I: Introduction to the Capillary Electrophoresis of Nucleic Acids) |
2000 | •• |
| 16791 |
|
Pevzner P.A. |
Computational Molecular Biology, Algorithmic |
2000 | •• |
| 16792 |
|
De Schutter (ed.) E., Cannon R. (ed.) |
Computational Neuroscience Realistic Modeling |
2000 | •• |
| 16797 |
|
Budowle B. |
DNA Typing Protocols |
2000 | •• |
| 16809 |
|
Habib N.A. |
Hepatocellular Carcinoma. Methods and Protocols |
2000 | •• |
| 16817 |
|
Copeland R.A. |
Enzymes: A Practical Introduction to Structure, Mechanism, and Data Analysis. |
2000 • | •• |
| 16819 |
|
Ormerod M.G. |
Flow Cytometry: A Practical Approach |
2000 • | •• |
| 16824 |
|
Scheper Th. (ed.) |
Advances in Biochemical Engineering/Biotechnology (Vol. 69: History of Modern Biotechnology I) |
2000 | •• |
|
|
Î ïðîåêòå